302 related articles for article (PubMed ID: 27481341)
1. Development of surface curcumin nanoparticles modified with biological macromolecules for anti-tumor effects.
Choi JS
Int J Biol Macromol; 2016 Nov; 92():850-859. PubMed ID: 27481341
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
3. Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells.
Anirudhan TS; Binusreejayan
Int J Biol Macromol; 2016 Jul; 88():222-35. PubMed ID: 27012895
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
5. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive copolymers based on pluronic P123-poly(β-amino ester): Synthesis, characterization and application of copolymer micelles.
Cai X; Liu M; Zhang C; Sun D; Zhai G
Colloids Surf B Biointerfaces; 2016 Jun; 142():114-122. PubMed ID: 26945163
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
[TBL] [Abstract][Full Text] [Related]
9. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
Lee WH; Loo CY; Rohanizadeh R
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
[TBL] [Abstract][Full Text] [Related]
10. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
[No Abstract] [Full Text] [Related]
11. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P
Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738
[TBL] [Abstract][Full Text] [Related]
13. PGMD/curcumin nanoparticles for the treatment of breast cancer.
Kumari M; Sharma N; Manchanda R; Gupta N; Syed A; Bahkali AH; Nimesh S
Sci Rep; 2021 Feb; 11(1):3824. PubMed ID: 33589661
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
15. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
18. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity.
Lee WH; Bebawy M; Loo CY; Luk F; Mason RS; Rohanizadeh R
J Biomed Nanotechnol; 2015 Jun; 11(6):1093-105. PubMed ID: 26353597
[TBL] [Abstract][Full Text] [Related]
20. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery.
Yoon IS; Park JH; Kang HJ; Choe JH; Goh MS; Kim DD; Cho HJ
Int J Pharm; 2015 Jul; 488(1-2):70-7. PubMed ID: 25900098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]